BackIntra-Cellular Therapies Overview

Intra-Cellular Therapies Net Income

Profitability analysis for ITCI.

Quarterly Net Income

-$16.89M
40.92% YoY

As of Dec 2024

Annual Net Income (TTM)

-$74.68M
46.54% YoY

Trailing 12 months ending Dec 2024

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...